A Phase II Clinical Trial of the PARP Inhibitor Talazoparib in BRCA1 and BRCA2 Wild-Type Patients

dbGaP FAQdbGaP Access Request Video Tutorial

Platforms

dbGaP

View in dbGaP

phs002803.v1.p1

APIs

Consent Codes

GRU

Focus / Diseases

Breast Neoplasms

Study Design

Clinical Trial

Data Types

OTHER, WXS

Subjects

20